Healthy Skepticism Library item: 8687

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Brenner R, Ellis-Grosse EJ, Echols R.
Moving goalposts--regulatory oversight of antibacterial drugs.
Nat Biotechnol 2006 Dec; 24:(12):1515-20
http://www.nature.com/nbt/journal/v24/n12/full/nbt1206-1515b.html

Abstract:

Is uncertainty concerning the regulation of antimicrobial drug trials stifling investment in infectious disease treatments? Here, experts from a large pharma company and a biotech firm provide their perspectives.

Keywords:
MeSH Terms: Anti-Bacterial Agents*/biosynthesis Anti-Bacterial Agents*/chemical synthesis Biotechnology/legislation & jurisprudence* Clinical Trials/standards* Drug Approval/legislation & jurisprudence* Drug Industry/legislation & jurisprudence* Microbial Sensitivity Tests/methods United States Substances: Anti-Bacterial Agents

Notes:

Free full text